摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

benzylidene-(3-chloro-1-propylamine) | 1026774-25-3

中文名称
——
中文别名
——
英文名称
benzylidene-(3-chloro-1-propylamine)
英文别名
——
benzylidene-(3-chloro-1-propylamine)化学式
CAS
1026774-25-3
化学式
C10H12ClN
mdl
——
分子量
181.665
InChiKey
YHDGLXVVWLCNHG-FMIVXFBMSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    270.1±23.0 °C(Predicted)
  • 密度:
    1.01±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.73
  • 重原子数:
    12.0
  • 可旋转键数:
    4.0
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.3
  • 拓扑面积:
    12.36
  • 氢给体数:
    0.0
  • 氢受体数:
    1.0

反应信息

  • 作为反应物:
    描述:
    benzylidene-(3-chloro-1-propylamine)di(tert-butyl)-biphenyllithium 作用下, 以 四氢呋喃 为溶剂, 反应 2.0h, 生成 2-苯基吡咯烷
    参考文献:
    名称:
    Hammett Correlation of Nornicotine Analogues in the Aqueous Aldol Reaction:  Implications for Green Organocatalysis
    摘要:
    A series of meta- and para-substituted 2-arylpyrrolidines were synthesized and examined for their ability to catalyze an aqueous aldol reaction under buffered conditions. Kinetic analysis of arylpyrrolidine-catalyzed reactions displayed a linear Hammett correlation with rho = 1.14 (R-2 = 0.996), indicating that the reaction is accelerated by electron-withdrawing aryl rings. These results show promise for the development of a synthetically viable aqueous organo-catalyst.
    DOI:
    10.1021/jo050161r
  • 作为产物:
    描述:
    3-氯丙胺盐酸盐苯甲醛 在 magnesium sulfate 、 三乙胺 作用下, 以 二氯甲烷 为溶剂, 反应 1.0h, 以83%的产率得到benzylidene-(3-chloro-1-propylamine)
    参考文献:
    名称:
    N-(ω-卤代烷基)-β-内酰胺对氢化铝锂的反应性:1-(1-芳基-3-羟丙基)氮丙啶和3-芳基-3-(N-丙基氨基)丙烷-1的新颖合成-ols。
    摘要:
    首次评估了4-芳基-1-(2-氯乙基)氮杂环丁烷-2-酮和4-芳基-1-(3-溴丙基)氮杂环丁烷-2-酮对氢化铝锂的反应性。通过将β-内酰胺前所未有地转化为2,3-未取代的氮丙啶衍生物,将4-芳基-1-(2-氯乙基)氮杂环丁烷-2-酮转化为新型的1-(1-芳基-3-羟丙基)氮丙啶。出乎意料的是,在使用LiAlH(4)处理后,4-芳基-1-(3-溴丙基)氮杂环丁烷-2-酮经历了向3-芳基-3-(N-丙基氨基)丙烷-1-醇的脱卤反应。通过使用苄基溴在乙腈中向3-芳基-3- [N-苄基-N-(2-溴乙基)氨基]丙烷-1的开环反应进一步修饰1-(1-芳基-3-羟丙基)氮丙啶-醇,并使用氯化铝(iii)在乙醚中,得到3-芳基-3- [N-(2-氯乙基)氨基]丙烷-1-醇。
    DOI:
    10.1039/b719686e
点击查看最新优质反应信息

文献信息

  • Synthesis of nitrated indenoisoquinolines as topoisomerase I inhibitors
    作者:Andrew Morrell、Smitha Antony、Glenda Kohlhagen、Yves Pommier、Mark Cushman
    DOI:10.1016/j.bmcl.2004.05.022
    日期:2004.7
    Indenoisoquinolines and dihydroindenoisoquinolines have been synthesized possessing a nitro-substituted isoquinoline ring in an effort to explore the effects of electron-withdrawing substituents on biological activity. The in vitro anticancer activities of these molecules have been tested in the National Cancer Institute's screen of 55 cell lines. The compounds have also been tested for topoisomerase I (topI) inhibition. The results indicate that these substances are a potent class of topI inhibitors with sub-micromolar cytotoxicity mean graph midpoints (MGM) and topI inhibition equal to camptothecin. (C) 2004 Elsevier Ltd. All rights reserved.
  • Optimization of the Indenone Ring of Indenoisoquinoline Topoisomerase I Inhibitors
    作者:Andrew Morrell、Michael Placzek、Seth Parmley、Brian Grella、Smitha Antony、Yves Pommier、Mark Cushman
    DOI:10.1021/jm070307+
    日期:2007.9.1
    Two series of indenoisoquinoline topoisomerase I inhibitors have been prepared to investigate optimal substituents on the indenone ring at the 9-position. The more exhaustive series was prepared using a nitrated isoquinoline ring that has been previously demonstrated to enhance biological activity. After preliminary biological evaluation, a more focused series of inhibitors was prepared utilizing a 2,3-dimethoxy-substituted isoquinoline ring. The results of the two series indicate the existence of superior functional groups such as methoxy, fluorine, and cyano for the indenoisoquinoline 9-position. Interestingly, these functional groups coincide with established structure-activity relationships for the 11-position of camptothecin.
  • MADZAKI, MITSUO;SINTO, NAOYA;XASIMOTO, KOITI;SINODZAKI, ATSUXIKO
    作者:MADZAKI, MITSUO、SINTO, NAOYA、XASIMOTO, KOITI、SINODZAKI, ATSUXIKO
    DOI:——
    日期:——
  • US4212877A
    申请人:——
    公开号:US4212877A
    公开(公告)日:1980-07-15
  • US4256756A
    申请人:——
    公开号:US4256756A
    公开(公告)日:1981-03-17
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫